By Ted Pigeon, Editor-in-Chief
An integral part of clinical neurology and neurosciences, neuroimaging training must be better harnessed and incorporated into the educational spectrum of the specialty.
By Laszlo Mechtler, MD and Joseph Fritz, PhD
The recent development of monoclonal antibodies for the treatment of migraine may have a significant impact on the field and mark a new chapter in patient care.
By Clinton G. Lauritsen, DO and Stephen D. Silberstein, MD
Treating the Cause, Not the Symptoms
By Paul G. Mathew, MD, FAAN, FAHS
Cannabis-derived therapies may offer a great opportunity to modulate the endocannabinoid system, but understanding the risks is paramount.
By Shawn Masia, MD and Ryan Zaklin, MD, MA
MOVEMENT DISORDERS FOCUS
By Rachel Dolhun, MD
An emerging class of potentially safer opioid medications will offer new challenges and opportunities for both patients and physicians.
By Gerard DeGregoris III, MD, Steve Arrieta, BA, Steven Mandel, MD, and Steve Aydin, DO
CPAs are not the most reliable and accurate sources of advice.
By David Mandell, JD, MBA and Carole Foos, CPA
Trump Picks Vocal Opponent of ACA as Health and Human Services Secretary